Global and United States Travelers Vaccination Market Report & Forecast 2022-2028

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
Market Analysis and Insights: Global and United States Travelers Vaccination Market

This report focuses on global and United States Travelers Vaccination market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Travelers Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Meningococcal Vaccine accounting for % of the Travelers Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Tourists was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Travelers Vaccination market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Travelers Vaccination Scope and Market Size

Travelers Vaccination market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Travelers Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Travelers Vaccination market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Travelers Vaccination market is segmented into

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Yellow Fever Vaccine

Hepatitis Vaccine

Cholera Vaccine

Other

Segment by Application, the Travelers Vaccination market is segmented into

Tourists

Students

Workers

Others

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Travelers Vaccination Market Share Analysis

Travelers Vaccination market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Travelers Vaccination business, the date to enter into the Travelers Vaccination market, Travelers Vaccination product introduction, recent developments, etc.

The major vendors covered:

GSK

Sanofi Pasteur

Merck

Pfizer

CNBG

Serum Institute of India

Biokangtai